Private Equity

Our innovative approach relies on technical excellence and deep-rooted understanding of industry dynamics. As just one example, we deftly identify the best solutions for dealing with regulatory restrictions, such as foreign control and cross-media ownership restrictions. We also identify and assess risk areas and create appropriate contractual mechanisms to protect client investments and lay the groundwork for any future regulatory changes. We structure pricing mechanisms calibrated to sector specifics (e.g., earnouts linked to clinical trial outcomes for pharma investments).

We work closely with our clients throughout negotiation and execution of private equity transactions. Our expertise in Italian and international investment funds allows us to prepare and manage investments, such as acquisition of majority and minority stakes, including by using financial leverage. We determine the best protection for investors, implement efficient governance solutions, and assess the legal and economic implications of negotiation options.

We also have a strong track record with complex public M&A deals and equity capital markets, including public offerings, IPOs, and capital increases for listed companies.

We offer high-level services for dealing with any issues stemming from investment and management of portfolio companies.

During divestment, our experience comes into play in drafting bid documents and analyzing various options, such as stapled W&I insurance. We also help clients pick among potential buyers and negotiate with the counterparties once selected, as well as outlining reinvestment structures and solutions.